Vietnam Generic Drug Market Growth, Demand and Challenges of the Key Industry Players 2024-2032
                     Vietnam Generic Drug 
Market Research and 
Forecast Report 2024-
2032
Format: PDF+EXCEL
© 2023 IMARC All Rights Reserved 
About IMARC Group
In ternat ional  Market  Analys is  Research and Consul t ing Group is  a leading adv iser  on management  
s t rategy and market  research wor ldwide.  We par tner  wi th c l ients  in  a l l  regions and indust ry  
vert ica ls  to  ident i fy  thei r  h ighest -value oppor tuni t ies,  address thei r  most  cr i t ica l  chal lenges,  and 
t ransform thei r  bus inesses.
IMARC’s in format ion products  inc lude major market ,  sc ient i f ic ,  economic and technological  
developments  for  bus iness leaders  in  pharmaceut ica l ,  indust r ia l ,  and h igh technology 
organizat ions.  Market  forecasts  and indust ry  analys is  for  b iotechnology,  advanced mater ia ls ,  
chemicals ,  food and beverage,  t ravel  and tour ism, nanotechnology and novel  process ing methods 
are at  the top of  the company’s  exper t ise.
IMARC’s ta i lored approach combines unfathomable ins ight  in to the dynamics o f  companies and 
markets wi th c lose cooperat ion at  a l l  levels  of  the c l ient  organizat ion.  This ensures that  our  c l ients 
achieve unmatchable compet i t ive advantage,  bui ld  more pro f ic ient  organizat ions,  and secure 
las t ing resul ts .
Acco r d ing  t o  t he  l a t es t  r e po r t  by  I M ARC  G r o up ,  t i t l ed  "V i e t n am G ene r i c  Dr ug  
M ar ke t :  I nd ust ry  T r ends ,  Sha re ,  S i ze ,  G row t h ,  O ppo r t un i t y  a nd  For ecas t  202 4 -
2032 , "  t he  V ie t nam  gene r i c  d r ug  m ar ke t  s i ze  i s  p r o jec t ed  t o  exh ib i t  a  g r o w t h  r a t e  
( CAG R)  o f  8 . 6 6% du r in g  20 24 - 20 32 .
Report Factors  Af fect ing the  Growth of  the V ie tnam Gener ic  Drug Indust ry :Government  In i t i at i ves  and Regulat ions:
The  go ve r n m en t  i s  im p lem en t in g  a  se r i es  o f  po l i c i es  an d  r egu la t i ons  t o  enc ou r a ge  
Highlight and t he  use  o f  gene r i c  d r ugs  as  a  cos t - e f f ec t i v e  a l t e r na t i v e  t o  b r and - nam e m e d ica t i o ns .  
Thes e  i n i t i a t i ves  i nc lude  s t r i ng en t  p r i ce  con t r o l s ,  i n cen t i v es  f o r  d om e s t i c  
p r od uc t i on ,  an d  m or e  s t r i n gen t  i n t e l l e c t ua l  p r o pe r t y  r egu la t i on s .  By  c r ea t i n g  a  
Description con du c i ve  env i r onm en t  f o r  g ene r ic  d r u g  m a nu f ac t u r i ng ,  t he  gove r nm e n t  i s  
enc ou r ag i ng  ph a r m aceu t i ca l  c om pa n ies  t o  i n ves t  i n  p r oduc in g  ge ne r i c  m ed ic ines .  
Th i s  i s  r es u l t i ng  i n  an  i nc r e ased  ava i la b i l i t y  o f  ge ne r i c  d r ugs  i n  t he  m ar ke t ,  m ak ing  
esse n t i a l  m ed ica t i ons  m or e  co s t - e f f ec t i ve  t o  a  b r oade r  s egm e n t  o f  t he  po pu la t i on .  
Thes e  p r oac t i ve  m e asu r e s  a l so  ensu r e  t ha t  t he  pha r m aceu t i ca l  i ndu s t r y  c om p l i es  
w i t h  i n t e r na t i on a l  qu a l i t y  s t anda r ds ,  en hanc i ng  cons um e r  con f i denc e  i n  gene r i c  
d r ug s .
Growing Healthcare Needs:
The r is ing heal thcare  needs of  the populat ion are  suppor t ing  the market  
growth in  V ie tnam. V ietnam is  w i tness ing an increase in  chron ic  
d iseases and other  hea l thcare  requi rements,  leading to a r ise in  the 
demand for  pharmaceut ica ls .  Gener ic  drugs are emerging as a  v iab le 
solu t ion to  meet  th is  growing demand.  
Report Pat ients  and heal thcare  prov iders  are  increas ing ly  choos ing gener ic  
drugs  because they of fer  the same qua l i ty  and e f f icacy as the i r  branded 
Highlight and counterpar ts  but  for  a  lesser  cost .  Th is  cost -e f fect iveness is  cruc ia l ,  
espec ia l ly  for  pat ients  wi th chron ic  i l lnesses who requ i re  long- term 
Description medicat ion.
Rising Patient Awareness:
The r is ing pat ient  awareness about  the safe ty  and ef f icacy of  gener ic  
drugs  is  s t rengthening the market  growth in  the count ry .  Educat ion and 
in format ion campaigns are he lp ing d ispe l  misconcept ions,  lead ing to 
greater  acceptance and t rust  in  gener ic  medicat ions.
Pat ien ts  and  hea l thcare  p rov ide rs  now recogn ize  tha t  gene r i c  d rugs  o f fe r  t he  
same therapeu t ic  bene f i t s  as  the i r  b randed  coun te rpa r t s  wh i le  be ing  more  
cos t -e f fec t ive .  Moreove r ,  the  r i s ing  conduc t ion  o f  va r ious  hea l thcare  
campa igns  and  educa t iona l  p rograms to  educa te  ind iv idua ls  abou t  t he  bene f i t s  
o f  gener ic  d rugs  is  fu r the r  ca ta lyz ing  the  demand.
Report 
Request  for  a  PDF sample  o f  th is  repor t :  
Highlight and h t tps : / /www. imarcgroup .com/v ie tnam-gene r i c -d rug-marke t / reques tsamp le
Description
Report Description
Vietnam Generic Drug Market Trends:
Vietnam is experiencing a demographic shi f t  w i th an aging populat ion. Elderly indiv iduals often 
require medicat ions for chronic condi t ions, making them more incl ined towards generic drugs 
due to the reduced f inancial  burden. Advancements in pharmaceutical  manufactur ing 
technologies are making i t  more cost-ef fect ive to produce high-qual i ty  generic drugs. 
This is not only increasing the avai labi l i ty  but a lso enhancing the qual i ty  of generic medicat ions 
in the market, faci l i tat ing their  acceptance. Furthermore, the increasing investments in the 
research and development of  generic drugs are bolster ing the market growth.
View Report TOC, Figures and Tables :  
https:/ /www.imarcgroup.com/vietnam-generic-drug-market
Therapy Area Insights:
• Central  Nervous System
• Cardiovascular
• Dermatology
• Genitour inary/Hormonal
• Respiratory
Report • Rheumatology
• Diabetes
Segmentation
• Oncology
• Others
Drug Delivery Insights:
• Oral
• In jectables
• Dermal/Topical
• Inhalers
Distribution Channel Insights:
• Retai l  Pharmacies
Report • Hospital  Pharmacies
Segmentation Regional Insights:
• Northern Vietnam
• Central  Vietnam
• Southern Vietnam
How has the Vietnam generic drug market performed so 
far and how will it perform in the coming years?
What has been the impact of COVID-19 on the Vietnam 
generic drug market?
What is the breakup of the Vietnam generic drug 
market on the basis of therapy area?
Key 
What is the breakup of the Vietnam generic drug 
Questions market on the basis of drug delivery?
Answered in What is the breakup of the Vietnam generic drug market on the basis of distribution channel?
the Report What are the various stages in the value chain of the 
Vietnam generic drug market?
What are the key driving factors and challenges in the 
Vietnam generic drug?
What is the structure of the Vietnam generic drug 
market and who are the key players?
What is the degree of competition in the Vietnam 
generic drug market?
1     P r e f a c e
2     S c o p e  a n d  M e t h o d o l o g y
    2 . 1     O b j e c t i v e s  o f  t h e  S t u d y
    2 . 2     S t a k e h o l d e r s
    2 . 3     D a t a  S o u r c e s
        2 . 3 . 1     P r i m a r y  S o u r c e s
        2 . 3 . 2     S e c o n d a r y  S o u r c e s
    2 . 4     M a r k e t  E s t i m a t i o n
Table of         2 . 4 . 1     B o t t o m - U p  A p p r o a c h        2 . 4 . 2     T o p - D o w n  A p p r o a c h
    2 . 5     F o r e c a s t i n g  M e t h o d o l o g y
3     E x e c u t i v e  S u m m a r y
4    V i e t n a m  G e n e r i c  D r u g  M a r k e t  -  I n t r o d u c t i o n
Contents     4 . 1     O v e r v i e w    4 . 2     M a r k e t  D y n a m i c s
    4 . 3     I n d u s t r y  T r e n d s
    4 . 4     C o m p e t i t i v e  I n t e l l i g e n c e
5    V i e t n a m  G e n e r i c  D r u g  M a r k e t  L a n d s c a p e
    5 . 1     H i s t o r i c a l  a n d  C u r r e n t  M a r k e t  T r e n d s  ( 2 0 1 8 - 2 0 2 3 )
    5 . 2     M a r k e t  F o r e c a s t  ( 2 0 2 4 - 2 0 3 2 )
6    V i e t n a m  G e n e r i c  D r u g  M a r k e t  -  B r e a k u p  b y  T h e r a p y  A r e a
    6 . 1     C e n t r a l  N e r v o u s  S y s t e m
        6 . 1 . 1  O v e r v i e w
        6 . 1 . 2  H i s t o r i c a l  a n d  C u r r e n t  M a r k e t  T r e n d s  ( 2 0 1 8 - 2 0 2 3 )
        6 . 1 . 3  M a r k e t  F o r e c a s t  ( 2 0 2 4 - 2 0 3 2 )
    6 . 2     C a r d i o v a s c u l a r
        6 . 2 . 1  O v e r v i e w
        6 . 2 . 2  H i s t o r i c a l  a n d  C u r r e n t  M a r k e t  T r e n d s  ( 2 0 1 8 - 2 0 2 3 )
        6 . 2 . 3  M a r k e t  F o r e c a s t  ( 2 0 2 4 - 2 0 3 2 )
       
    6 . 3     D e r m a to l o g y
        6 . 3 . 1  O v e r v i e w
        6 . 3 . 2  H i s t o r i c a l  a n d  C u r r e n t  M a r k e t  T r e n d s  ( 2 0 1 8 - 2 0 2 3 )
        6 . 3 . 3  M a r k e t  F o r e c a s t  ( 2 0 2 4 - 2 0 3 2 )
    6 . 4     G e n i t o u r i n a r y / H o r m o n a l
        6 . 4 . 1  O v e r v i e w
        6 . 4 . 2  H i s t o r i c a l  a n d  C u r r e n t  M a r k e t  T r e n d s  ( 2 0 1 8 - 2 0 2 3 )
        6 . 4 . 3  M a r k e t  F o r e c a s t  ( 2 0 2 4 - 2 0 3 2 )
    6 . 5     R e s p i r a t o r y
        6 . 5 . 1  O v e r v i e w
Table of         6 . 5 . 2  H i s t o r i c a l  a n d  C u r r e n t  M a r k e t  T r e n d s  ( 2 0 1 8 - 2 0 2 3 )        6 . 5 . 3  M a r k e t  F o r e c a s t  ( 2 0 2 4 - 2 0 3 2 )
    6 . 6     R h e u m a t o l o g y
        6 . 6 . 1  O v e r v i e w
Contents         6 . 6 . 2  H i s t o r i c a l  a n d  C u r r e n t  M a r k e t  T r e n d s  ( 2 0 1 8 - 2 0 2 3 )
        6 . 6 . 3  M a r k e t  F o r e c a s t  ( 2 0 2 4 - 2 0 3 2 )
    6 . 7     D i a b e t e s
        6 . 7 . 1  O v e r v i e w
        6 . 7 . 2  H i s t o r i c a l  a n d  C u r r e n t  M a r k e t  T r e n d s  ( 2 0 1 8 - 2 0 2 3 )
        6 . 7 . 3  M a r k e t  F o r e c a s t  ( 2 0 2 4 - 2 0 3 2 )
    6 . 8     O n c o l o g y
        6 . 8 . 1  O v e r v i e w
        6 . 8 . 2  H i s t o r i c a l  a n d  C u r r e n t  M a r k e t  T r e n d s  ( 2 0 1 8 - 2 0 2 3 )
        6 . 8 . 3  M a r k e t  F o r e c a s t  ( 2 0 2 4 - 2 0 3 2 )
    6 . 9     O th e r s
        6 . 9 . 1  H i s t o r i c a l  a n d  C u r r e n t  M a r k e t  T r e n d s  ( 2 0 1 8 - 2 0 2 3 )
        6 . 9 . 2  M a r k e t  F o r e c a s t  ( 2 0 2 4 - 2 0 3 2 )
F o r  m o r e  i n f o r m a t io n ,  v i s i t :  
ht tps : / /www. imarcgroup .com/v ie tnam-gene r i c -drug -market / t
oc
Partial List of Clients
Partial List of Clients
Disclaimer
© 2024  IMARC Al l  R ights  Reserved 
Th is  Pub l i ca t ion  and  a l l  i t ’ s  con ten ts  un less  o therw ise  men t i oned  a re  copy r i gh ted  in  the  name o f  
I n t e rna t i ona l  Marke t  Ana lys i s  Research  and  Consu l t ing  ( IMARC) .  No  pa r t  o f  t h i s  pub l i ca t ion  may  be  
rep roduced ,  repackaged ,  red i s t r i bu ted  o r  res o ld  i n  who le  o r  i n  any  pa r t .  The  pub l i ca t ion  may  a l so  
no t  be  used  i n  any  f o rm o r  by  and means  g raph i c  e lec t ron ic  o r  mechan ic a l ,  i nc lud ing  pho tocopy ing ,  
reco rd ing ,  t ap ing  o r  by  i n fo rmat i on  s to rage  o r  re t r ieva l ,  o r  by  any  o the r  f o rm,  w i t hou t  the  exp ress  
c ons en t  o f  I n t e rna t iona l  Marke t  Ana lys i s  Research  and  Consu l t i ng  ( IMARC) .
Disc la imer :  Al l  con ten ts  and  da ta  o f  t h i s  pub l i c a t i on ,  i nc lud ing  fo recas t s ,  da ta  ana lys i s  and  op in ion  
have  been  based  on  in f o rmat ion  and  sources  be l ieved  to  be  accu ra te  and  re l iab le  a t  t he  t ime  o f  
pub l i sh ing .  In t e rna t i ona l  Ma rke t  Ana l ys is  Research  and  Consu l t ing  makes  no  rep resen ta t ion  o f  
war ran t y  o f  any  k ind  as  to  t he  acc u racy  o r  comp le teness  o f  any  I n fo rmat i on  p rov ided .  IMARC 
accep ts  no  l i ab i l i t y  wha tsoever  f o r  any  los s  o r  damage  resu l t i ng  f rom op in ion ,  e r ro rs  o r  
i naccu rac ies  i f  any  f ound  th is  pub l i ca t ion .
IMARC,  IMARC Group  and  G loba l  Therapy  I ns igh t  Ser i es  a re  reg is t e red  t rademarks  o f  I n te rna t iona l  
Marke t  Ana lys i s  Research  and  Consu l t ing .  A l l  o the r  t rademarks  used  i n  th i s  pub l i ca t i on  a re  
reg i s te red  t rademarks  o f  t he i r  r espec t i ve  compan ies .
Contact Us
Visit us at :
https://www.imarcgroup.com
+1-631-791-1145
[email protected]
Stay With Us: